MedPath
NMPA Approval

Erlotinib Hydrochloride Tablets

国药准字H20204030

June 12, 2024

国药准字H20193262

Drug Information

盐酸厄洛替尼片

片剂

0.1g

化学药品

June 12, 2024

Company Information

Applicant Company

上海市浦东新区惠南镇沪南公路9125号

Manufacturing Company

上海市浦东新区惠南镇沪南公路9125号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸厄洛替尼片 - NMPA 批准文号 | MedPath